MX2013012188A - Procesos para la elaboracion de depsipeptidos macrociclicos y nuevos intermediarios. - Google Patents

Procesos para la elaboracion de depsipeptidos macrociclicos y nuevos intermediarios.

Info

Publication number
MX2013012188A
MX2013012188A MX2013012188A MX2013012188A MX2013012188A MX 2013012188 A MX2013012188 A MX 2013012188A MX 2013012188 A MX2013012188 A MX 2013012188A MX 2013012188 A MX2013012188 A MX 2013012188A MX 2013012188 A MX2013012188 A MX 2013012188A
Authority
MX
Mexico
Prior art keywords
manufacture
processes
new intermediates
depsipeptides
macrocyclic depsipeptides
Prior art date
Application number
MX2013012188A
Other languages
English (en)
Other versions
MX337526B (es
Inventor
Murat Acemoglu
Heribert Hellstern
Felix Kollmer
John Lopez
Robert Schreiber
Christian Sprecher
Hans Stettler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013012188(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2013012188A publication Critical patent/MX2013012188A/es
Publication of MX337526B publication Critical patent/MX337526B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cookers (AREA)
  • Cereal-Derived Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención se refiere a un método o proceso para la elaboración química de los depsipéptidos de la fórmula I: (ver Fórmula) en donde los símbolos tienen el significado definido en la descripción, a nuevos intermediarios y su elaboración, así como a las modalidades de la invención relacionadas.
MX2013012188A 2011-04-20 2012-04-19 Procesos para la elaboracion de depsipeptidos macrociclicos y nuevos intermediarios. MX337526B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161477319P 2011-04-20 2011-04-20
PCT/IB2012/051977 WO2012143888A1 (en) 2011-04-20 2012-04-19 Processes for the manufacture of macrocyclic depsipeptides and new intermediates

Publications (2)

Publication Number Publication Date
MX2013012188A true MX2013012188A (es) 2013-11-04
MX337526B MX337526B (es) 2016-03-09

Family

ID=46317455

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012188A MX337526B (es) 2011-04-20 2012-04-19 Procesos para la elaboracion de depsipeptidos macrociclicos y nuevos intermediarios.

Country Status (21)

Country Link
US (2) US8614289B2 (es)
EP (1) EP2699585A1 (es)
JP (2) JP5951006B2 (es)
KR (1) KR101580729B1 (es)
CN (2) CN103476789B (es)
AR (1) AR086168A1 (es)
AU (1) AU2012245980B2 (es)
BR (1) BR112013026660A2 (es)
CA (1) CA2833109A1 (es)
CL (2) CL2013003037A1 (es)
CO (1) CO6801799A2 (es)
EA (2) EA201500734A1 (es)
GT (1) GT201300256A (es)
IL (1) IL228727A0 (es)
MA (1) MA35034B1 (es)
MX (1) MX337526B (es)
PE (1) PE20141206A1 (es)
SG (1) SG193918A1 (es)
TN (1) TN2013000385A1 (es)
TW (1) TW201249863A (es)
WO (1) WO2012143888A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2183273B1 (en) 2007-08-17 2017-04-05 Novartis AG Cyclic depsipeptides
US8680054B2 (en) 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
US8614289B2 (en) 2011-04-20 2013-12-24 Novartis Ag Processes for the manufacture of macrocyclic depsipeptides and new intermediates
US8987413B2 (en) * 2012-10-09 2015-03-24 Novartis Ag Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
US9067978B2 (en) * 2012-10-09 2015-06-30 Novartis Ag Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
US20170022254A1 (en) 2014-04-08 2017-01-26 Novartis Ag Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates
MX2021001566A (es) * 2015-05-20 2022-09-12 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidicos como anthelminticos.
WO2017049128A1 (en) 2015-09-17 2017-03-23 Massachusetts Institute Of Technology Methods and systems for solid phase peptide synthesis
KR102031186B1 (ko) * 2017-01-11 2019-11-08 주식회사 엘지생활건강 단백질 강도 강화용 조성물
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3043252C2 (de) 1980-11-15 1982-12-02 Degussa Ag, 6000 Frankfurt Cyclische Acetale von N-Acylglutaminsäure -γ- semialdehyden, Verfahren zu deren Herstellung und ihre Verwendung
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
DE4421113A1 (de) 1994-06-16 1995-12-21 Biotechnolog Forschung Gmbh Chondramide, Gewinnungsverfahren, Mittel mit Chondramiden und Mischkultur zur Chondramid-Gewinnung
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
JP2000154198A (ja) 1998-11-20 2000-06-06 Nisshin Flour Milling Co Ltd 環状デプシペプチドの固相合成方法及びその中間体
GB0108234D0 (en) * 2001-04-02 2001-05-23 Pharma Mar Sa Process for producing trunkamide A compounds
US20040110228A1 (en) 2002-04-01 2004-06-10 Mcalpine Shelli R. Combinatorial organic synthesis of unique biologically active compounds
KR101099409B1 (ko) 2003-06-06 2011-12-27 아렉시스 악티에볼라그 피부 상태 또는 암 치료를 위한 ｓｃｃｅ 저해제로서의융합된 헤테로사이클 화합물의 용도
GB0322140D0 (en) 2003-09-22 2003-10-22 Pfizer Ltd Combinations
WO2005075667A1 (en) 2004-02-03 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7)
AU2007220042A1 (en) 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer
GB0715750D0 (en) 2007-08-13 2007-09-19 Karus Therapeutics Ltd Chemical compounds
EP2183270B1 (en) 2007-08-17 2014-12-17 Novartis AG Use of cyclic depsipeptides to inhibit kallikrein 7
EP2183273B1 (en) 2007-08-17 2017-04-05 Novartis AG Cyclic depsipeptides
DE102007052391A1 (de) 2007-10-31 2009-05-07 Henkel Ag & Co. Kgaa Mattwachs
US20110112121A1 (en) 2009-07-06 2011-05-12 Joerg Berghausen Pharmaceutical Compositions and Solid Forms
US20120064013A1 (en) 2010-02-03 2012-03-15 David Marcos Foamable topical composition
KR101004362B1 (ko) 2010-03-19 2010-12-28 가톨릭대학교 산학협력단 자가 면역 질환 예방 및 치료용 ＴＮＦ－α와 ＴＷＥＡＫ 이중 길항제
US20120064136A1 (en) 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions
ES2720648T3 (es) 2011-01-24 2019-07-23 Anterios Inc Composiciones de nanopartículas
WO2012103038A2 (en) 2011-01-24 2012-08-02 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
US8680054B2 (en) 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
US8614289B2 (en) 2011-04-20 2013-12-24 Novartis Ag Processes for the manufacture of macrocyclic depsipeptides and new intermediates
US9067978B2 (en) 2012-10-09 2015-06-30 Novartis Ag Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
US8987413B2 (en) 2012-10-09 2015-03-24 Novartis Ag Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
US20170022254A1 (en) 2014-04-08 2017-01-26 Novartis Ag Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates

Also Published As

Publication number Publication date
US20120277406A1 (en) 2012-11-01
SG193918A1 (en) 2013-11-29
WO2012143888A1 (en) 2012-10-26
EA201391554A1 (ru) 2014-11-28
EA025546B1 (ru) 2017-01-30
PE20141206A1 (es) 2014-09-28
TW201249863A (en) 2012-12-16
CA2833109A1 (en) 2012-10-26
EA201500734A1 (ru) 2015-11-30
KR101580729B1 (ko) 2015-12-28
AU2012245980B2 (en) 2015-01-29
GT201300256A (es) 2015-02-19
US8614289B2 (en) 2013-12-24
CL2013003037A1 (es) 2014-10-03
US20140080995A1 (en) 2014-03-20
IL228727A0 (en) 2013-12-31
CN103476789A (zh) 2013-12-25
AU2012245980A1 (en) 2013-10-03
KR20130140204A (ko) 2013-12-23
TN2013000385A1 (en) 2015-01-20
JP2014511899A (ja) 2014-05-19
MA35034B1 (fr) 2014-04-03
AR086168A1 (es) 2013-11-27
CN103476789B (zh) 2016-11-09
CL2015000688A1 (es) 2015-06-05
EP2699585A1 (en) 2014-02-26
BR112013026660A2 (pt) 2016-09-06
JP5951006B2 (ja) 2016-07-13
CN104804072A (zh) 2015-07-29
JP2016164158A (ja) 2016-09-08
US9278997B2 (en) 2016-03-08
CO6801799A2 (es) 2013-11-29
MX337526B (es) 2016-03-09

Similar Documents

Publication Publication Date Title
TN2013000385A1 (en) Processes for the manufacture of macrocyclic depsipeptides and new intermediates
WO2014057418A3 (en) Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
IN2015DN01812A (es)
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
EP2540796A4 (en) β-SIALONE PHOSPHORES, USES THEREOF, METHOD FOR THE PRODUCTION OF β-SIALONE PHOSPHORUS
UA105785C2 (uk) Спосіб очищення ліпопептидів
MX369049B (es) Aparato para producir aceros recocidos y proceso para producir dichos aceros.
IN2012KN02804A (es)
MX360806B (es) Benzoxazinonas de carbamato.
NZ711192A (en) Process for making benzoxazepin compounds
EA201500234A1 (ru) Способ получения бензоксазинонов
MX344858B (es) Nuevo procedimiento para la síntesis de rifaximina y una nueva forma pseudocristalina de rifaximina obtenida con el mismo.
MX363058B (es) Carbamatos, proceso para su preparación y uso para la preparación de benzoxazinonas.
MY164954A (en) Method for purifying organic diphosphite compounds
EP2700322A4 (en) COMPOSITION CONTAINING SCIRPUSIN B, AND PROCESS FOR PRODUCING COMPOSITION CONTAINING SCIRPUSIN B
HK1199242A1 (zh) 生產 -丁二烯的方法
MX2012010317A (es) ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
MX2014000916A (es) Proceso para la produccion continua de polieteroles.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
WO2013054204A3 (en) A process for making an intermediate of cabazitaxel
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
WO2014102820A3 (en) Rivaroxaban intermediate and preparation thereof
MX2014006597A (es) Polimeros de condensacion de acido mandelico.
MX2014002274A (es) Procedimiento para preparar [3-[(6-cloro-3-piridinil)metil]-2-tiaz olidiniliden]cianamida.

Legal Events

Date Code Title Description
FG Grant or registration